Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
financials
Pharma
AstraZeneca plots NYSE listing amid UK industry pullback
The move will replace AZ’s existing U.S. listing of American Depositary Receipts on the Nasdaq, which simplify U.S. investing in foreign companies.
Fraiser Kansteiner
Sep 29, 2025 10:05am
Sarepta extends $700M debt to 2030 amid Elevidys uncertainty
Aug 21, 2025 10:52am
Top 20 pharma companies by 2024 revenue
Apr 21, 2025 3:00am
J&J lifts 2025 sales guidance despite looming tariff threat
Apr 15, 2025 11:55am
Novartis unveils $23B investment to beef up US manufacturing, R&D
Apr 10, 2025 3:18pm
Trump's 'major' pharma tariff threat sends stocks down
Apr 9, 2025 10:50am